Literature DB >> 13816018

Use of 5-fluorouracil in treatment of bladder carcinomas.

T L DEREN, W L WILSON.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS/therapy; CARCINOMA/therapy; URACIL/related compounds

Mesh:

Substances:

Year:  1960        PMID: 13816018     DOI: 10.1016/s0022-5347(17)65724-0

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  6 in total

1.  A clinical study of 5-fluorouracil in a variety of far advanced human malignancies.

Authors:  J E WHITE; W N RICKETTS; W J STRUDWICK
Journal:  J Natl Med Assoc       Date:  1962-05       Impact factor: 1.798

Review 2.  Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy.

Authors:  Huai-Liang Wu; Yue Gong; Peng Ji; Yi-Fan Xie; Yi-Zhou Jiang; Guang-Yu Liu
Journal:  J Hematol Oncol       Date:  2022-04-27       Impact factor: 23.168

3.  Cancer of the bladder. Combined 5-fluorouracil and cobalt-60 teletherapy.

Authors:  J J Kaufman; E A Langdon; J J Stein; F B Burt
Journal:  Calif Med       Date:  1964-11

4.  Effects of single chemotherapeutic agents on development of urinary bladder tumor induced by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) in rats.

Authors:  K Babaya; S Takahashi; H Momose; H Matsuki; K Sasaki; S Samma; S Ozono; Y Hirao; E Okajima
Journal:  Urol Res       Date:  1987

5.  Cytotoxic chemotherapy in carcinoma of the bladder: a review.

Authors:  P H Smith
Journal:  J R Soc Med       Date:  1980-03       Impact factor: 18.000

6.  A REPORT OF THE SYSTEMIC USE OF 5-FLUOROURACIL IN THE TREATMENT OF CHINESE CANCER PATIENTS.

Authors:  D P CHAN; J H HO; A W WOO
Journal:  Br J Cancer       Date:  1964-03       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.